Found: 171
Select item for more details and to access through your institution.
Small cell pattern of ALK‐negative anaplastic large cell lymphoma with double‐hit rearrangements of DUSP22 and TP63.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.
- Published in:
- Cancer Science, 2024, v. 115, n. 6, p. 2002, doi. 10.1111/cas.16158
- By:
- Publication type:
- Article
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 697, doi. 10.1007/s12185-024-03750-y
- By:
- Publication type:
- Article
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203
- Published in:
- Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3272
- By:
- Publication type:
- Article
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 5, p. 718, doi. 10.3390/v16050718
- By:
- Publication type:
- Article
R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 849, doi. 10.1111/bjh.19213
- By:
- Publication type:
- Article
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 475, doi. 10.1007/s00277-023-05428-7
- By:
- Publication type:
- Article
miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma.
- Published in:
- Cancer Science, 2024, v. 115, n. 2, p. 452, doi. 10.1111/cas.16027
- By:
- Publication type:
- Article
Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System.
- Published in:
- Oncology Letters, 2024, v. 27, n. 2, p. N.PAG, doi. 10.3892/ol.2023.14193
- By:
- Publication type:
- Article
Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3252
- By:
- Publication type:
- Article
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas.
- Published in:
- Cancer Science, 2023, v. 114, n. 12, p. 4691, doi. 10.1111/cas.15995
- By:
- Publication type:
- Article
Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR‐106a‐5p and miR‐146a‐5p in multiple myeloma.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 426, doi. 10.1111/bjh.19049
- By:
- Publication type:
- Article
Bilateral Popeye's Sign.
- Published in:
- Internal Medicine, 2023, v. 62, n. 18, p. 2757, doi. 10.2169/internalmedicine.1093-22
- By:
- Publication type:
- Article
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 3, p. 323, doi. 10.1007/s12185-023-03627-6
- By:
- Publication type:
- Article
Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy.
- Published in:
- Internal Medicine, 2023, v. 62, n. 16, p. 2401, doi. 10.2169/internalmedicine.0849-22
- By:
- Publication type:
- Article
Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0285947
- By:
- Publication type:
- Article
Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01.
- Published in:
- Cancer Science, 2023, v. 114, n. 5, p. 2098, doi. 10.1111/cas.15746
- By:
- Publication type:
- Article
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia.
- Published in:
- Cancer Science, 2023, v. 114, n. 4, p. 1297, doi. 10.1111/cas.15720
- By:
- Publication type:
- Article
Neurolymphomatosis of cranial nerves as the responsible lesions for the vocal cord paralysis and facial nerve palsy in a patient with diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 481, doi. 10.1007/s00277-022-05038-9
- By:
- Publication type:
- Article
Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3134, doi. 10.1002/cam4.5237
- By:
- Publication type:
- Article
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms.
- Published in:
- Infection & Drug Resistance, 2023, v. 16, p. 509, doi. 10.2147/IDR.S396271
- By:
- Publication type:
- Article
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 1, p. 100, doi. 10.1007/s12185-022-03455-0
- By:
- Publication type:
- Article
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4267, doi. 10.1111/cas.15556
- By:
- Publication type:
- Article
Simultaneous detection of JAK2, CALR, and MPL mutations and quantitation of JAK2 V617F allele burden in myeloproliferative neoplasms using the quenching probe-Tm method in i-densy IS-5320.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 6, p. 1102, doi. 10.1111/ijlh.13938
- By:
- Publication type:
- Article
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 4, p. 563, doi. 10.1007/s12185-022-03379-9
- By:
- Publication type:
- Article
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3267, doi. 10.1111/cas.15484
- By:
- Publication type:
- Article
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 2, p. 199, doi. 10.1007/s12185-022-03328-6
- By:
- Publication type:
- Article
Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 1, p. 122, doi. 10.1007/s12185-022-03338-4
- By:
- Publication type:
- Article
Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 583, doi. 10.1093/jjco/hyac039
- By:
- Publication type:
- Article
The outcome of watchful waiting in patients with previously treated follicular lymphoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 10, p. 2106, doi. 10.1002/cam4.4588
- By:
- Publication type:
- Article
Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 5, p. 979, doi. 10.1007/s00277-022-04801-2
- By:
- Publication type:
- Article
Neurosarcoidosis Presenting with Prominent Periventricular White-Matter Lesions during Steroid Treatment for Autoimmune Hepatitis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 2723, doi. 10.2147/IDR.S360238
- By:
- Publication type:
- Article
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4694, doi. 10.3390/ijms23094694
- By:
- Publication type:
- Article
A case of neuroleukemiosis: The usefulness of nerve ultrasound as a diagnostic tool.
- Published in:
- Muscle & Nerve, 2022, v. 65, n. 5, p. E19, doi. 10.1002/mus.27508
- By:
- Publication type:
- Article
Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric Cancer.
- Published in:
- Internal Medicine, 2022, v. 61, n. 8, p. 1231, doi. 10.2169/internalmedicine.7986-21
- By:
- Publication type:
- Article
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 2919, doi. 10.3390/ijms23062919
- By:
- Publication type:
- Article
Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant.
- Published in:
- Human Genome Variation, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41439-022-00185-x
- By:
- Publication type:
- Article
Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy.
- Published in:
- International Journal of Hematology-Oncology & Stem Cell Research, 2022, v. 16, n. 1, p. 1
- By:
- Publication type:
- Article
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum.
- Published in:
- EJHaem, 2021, v. 2, n. 4, p. 765, doi. 10.1002/jha2.284
- By:
- Publication type:
- Article
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2131, doi. 10.1007/s10147-021-02006-7
- By:
- Publication type:
- Article
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 217, doi. 10.1111/bjh.17717
- By:
- Publication type:
- Article
Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3627, doi. 10.1111/cas.15040
- By:
- Publication type:
- Article
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 9, p. 1724, doi. 10.3390/diagnostics11091724
- By:
- Publication type:
- Article
Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 9, p. 1372, doi. 10.1093/jjco/hyab112
- By:
- Publication type:
- Article
Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2845, doi. 10.1111/cas.14937
- By:
- Publication type:
- Article